Antiangiogenic therapy and p53.

Science

Volumn 297, Issue 5581, 2002, Pages

  Browder, Timothy ^a   Folkman, Judah ^a   Hahnfeldt, Philip ^a   Heymach, John ^a   Hlatky, Lynn ^a   Kieran, Mark ^a   Rogers, Michael S ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; GROWTH FACTOR RECEPTOR; GROWTH PROMOTOR; PROTEIN TYROSINE KINASE; VASCULOTROPIN RECEPTOR;

ANIMAL; CELL CULTURE; EXPERIMENTAL NEOPLASM; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NOTE; PATHOLOGY; TUMOR SUPPRESSOR GENE; VASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANIMALS; GENES, P53; GROWTH SUBSTANCES; HUMANS; MICE; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; TUMOR CELLS, CULTURED;

EID: 0344288376     PISSN: None     EISSN: 10959203     Source Type: Journal    
DOI: None     Document Type: Note

References (0)